Michael R. Emmert‐Buck

20.9k total citations · 2 hit papers
177 papers, 10.8k citations indexed

About

Michael R. Emmert‐Buck is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Michael R. Emmert‐Buck has authored 177 papers receiving a total of 10.8k indexed citations (citations by other indexed papers that have themselves been cited), including 123 papers in Molecular Biology, 51 papers in Cancer Research and 24 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Michael R. Emmert‐Buck's work include Molecular Biology Techniques and Applications (62 papers), Cancer Genomics and Diagnostics (32 papers) and Gene expression and cancer classification (21 papers). Michael R. Emmert‐Buck is often cited by papers focused on Molecular Biology Techniques and Applications (62 papers), Cancer Genomics and Diagnostics (32 papers) and Gene expression and cancer classification (21 papers). Michael R. Emmert‐Buck collaborates with scholars based in United States, China and Chile. Michael R. Emmert‐Buck's co-authors include Lance A. Liotta, John W. Gillespie, Rodrigo Chuaqui, Nicole L. Simone, Kristina A. Cole, Mark J. Roth, W. Marston Linehan, Cloud P. Paweletz, Robert F. Bonner and Paul H. Duray and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Michael R. Emmert‐Buck

177 papers receiving 10.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front

2001 746 citations John W. Gillespie, Michael R. Emmert‐Buck et al. Oncogene profile →
Laser Capture Microdissection: Molecular Analysis of Tissue

1997 736 citations Robert F. Bonner, Michael R. Emmert‐Buck et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael R. Emmert‐Buck United States	55	6.9k	2.6k	2.1k	1.4k	1.3k	177	10.8k
David E. Misek United States	53	7.1k 1.0×	2.0k 0.8×	2.0k 0.9×	1.0k 0.7×	1.4k 1.0×	95	11.1k
Fredrik Pontén Sweden	60	8.3k 1.2×	2.8k 1.1×	3.7k 1.8×	1.8k 1.3×	1.1k 0.8×	272	14.2k
Rork Kuick United States	56	7.8k 1.1×	3.4k 1.3×	2.4k 1.2×	1.2k 0.9×	639 0.5×	156	13.0k
Samuel C. Mok United States	67	7.7k 1.1×	3.7k 1.4×	3.5k 1.7×	1.1k 0.8×	501 0.4×	243	14.2k
Julio E. Celis Denmark	57	8.2k 1.2×	1.0k 0.4×	1.5k 0.7×	516 0.4×	1.8k 1.3×	218	11.9k
Karl R. Clauser United States	49	7.2k 1.0×	1.1k 0.4×	2.2k 1.0×	553 0.4×	3.0k 2.2×	84	11.6k
Wilhelm Krek Switzerland	52	7.6k 1.1×	2.3k 0.9×	3.7k 1.8×	1.0k 0.7×	314 0.2×	93	10.8k
Alexander D. Borowsky United States	51	4.7k 0.7×	1.6k 0.6×	2.6k 1.2×	1.3k 0.9×	334 0.3×	197	8.7k
Paul H. Duray United States	58	5.2k 0.8×	1.5k 0.6×	4.6k 2.2×	3.2k 2.3×	335 0.3×	155	14.0k
Sean C. Bendall United States	44	9.2k 1.3×	1.4k 0.6×	2.7k 1.3×	417 0.3×	867 0.6×	113	14.5k

Countries citing papers authored by Michael R. Emmert‐Buck

Since Specialization

Citations

This map shows the geographic impact of Michael R. Emmert‐Buck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael R. Emmert‐Buck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael R. Emmert‐Buck more than expected).

Fields of papers citing papers by Michael R. Emmert‐Buck

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael R. Emmert‐Buck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael R. Emmert‐Buck. The network helps show where Michael R. Emmert‐Buck may publish in the future.

Co-authorship network of co-authors of Michael R. Emmert‐Buck

This figure shows the co-authorship network connecting the top 25 collaborators of Michael R. Emmert‐Buck. A scholar is included among the top collaborators of Michael R. Emmert‐Buck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael R. Emmert‐Buck. Michael R. Emmert‐Buck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Diaz, Giacomo, Ronald E. Engle, Ashley Tice, et al.. (2018). Molecular Signature and Mechanisms of Hepatitis D Virus–Associated Hepatocellular Carcinoma. Molecular Cancer Research. 16(9). 1406–1419. 44 indexed citations

Rosenberg, Avi Z., Patricia Fetsch, Liqiang Xi, et al.. (2016). High-Throughput Microdissection for Next-Generation Sequencing. PLoS ONE. 11(3). e0151775–e0151775. 17 indexed citations

Hanson, Jeffrey C., Jaime Rodriguez‐Canales, Daniel Lubelski, et al.. (2013). Analysis of Transcription Factor mRNAs in Identified Oxytocin and Vasopressin Magnocellular Neurons Isolated by Laser Capture Microdissection. PLoS ONE. 8(7). e69407–e69407. 7 indexed citations

Roy‐Chowdhuri, Sinchita, Liqiang Xi, Trinh Pham, et al.. (2011). EGFR and KRAS mutation analysis in cytologic samples of lung adenocarcinoma enabled by laser capture microdissection. Modern Pathology. 25(4). 548–555. 56 indexed citations

Tangrea, Michael A., Jeffrey C. Hanson, Robert F. Bonner, et al.. (2011). Immunoguided Microdissection Techniques. Methods in molecular biology. 755. 57–66. 11 indexed citations

Hipp, Jason, Jerome Cheng, Liron Pantanowitz, et al.. (2011). Image microarrays (IMA): Digital pathology’s missing tool. Journal of Pathology Informatics. 2(1). 47–47. 8 indexed citations

Eberle, Franziska, Jeffrey C. Hanson, Jonathan Keith Killian, et al.. (2010). Immunoguided Laser Assisted Microdissection Techniques for DNA Methylation Analysis of Archival Tissue Specimens. Journal of Molecular Diagnostics. 12(4). 394–401. 31 indexed citations

Zoon, Christine K., et al.. (2009). Current molecular diagnostics of breast cancer and the potential incorporation of microRNA. Expert Review of Molecular Diagnostics. 9(5). 455–466. 42 indexed citations

Killian, Jonathan Keith, Sven Bilke, Sean Davis, et al.. (2009). Large-Scale Profiling of Archival Lymph Nodes Reveals Pervasive Remodeling of the Follicular Lymphoma Methylome. Cancer Research. 69(3). 758–764. 36 indexed citations

10.

Erickson, Heidi S., Paul S. Albert, John W. Gillespie, et al.. (2009). Quantitative RT-PCR gene expression analysis of laser microdissected tissue samples. Nature Protocols. 4(6). 902–922. 77 indexed citations

11.

Gannot, Gallya, Michael A. Tangrea, Rodrigo Chuaqui, John W. Gillespie, & Michael R. Emmert‐Buck. (2007). Layered Peptide Arrays. Annals of the New York Academy of Sciences. 1098(1). 451–453. 1 indexed citations

12.

Best, Carolyn J.M., John W. Gillespie, Yajun Yi, et al.. (2005). Molecular Alterations in Primary Prostate Cancer after Androgen Ablation Therapy. Clinical Cancer Research. 11(19). 6823–6834. 137 indexed citations

13.

Gannot, Gallya, Michael A. Tangrea, John W. Gillespie, et al.. (2005). Layered Peptide Arrays. Journal of Molecular Diagnostics. 7(4). 427–436. 15 indexed citations

14.

Emmert‐Buck, Michael R., et al.. (2003). Handling of Clinical Tissue Specimens for Molecular Profiling Studies. Current Issues in Molecular Biology. 5(2). 27–35. 22 indexed citations

15.

Hu, Nan, Alisa M. Goldstein, Paul S. Albert, et al.. (2003). Evidence for a familial esophageal cancer susceptibility gene on chromosome 13.. PubMed. 12(10). 1112–5. 17 indexed citations

16.

Hu, Nan, Chaoyu Wang, Xiao‐You Han, et al.. (2003). Evaluation of BRCA2 in the genetic susceptibility of familial esophageal cancer. Oncogene. 23(3). 852–858. 64 indexed citations

17.

Strausberg, Robert L., Robert L. Strausberg, Kenneth H. Buetow, et al.. (2000). The Cancer Genome Anatomy Project: building an annotated gene index. Trends in Genetics. 16(3). 103–106. 90 indexed citations

18.

Best, Carolyn J.M., John W. Gillespie, John D. Pfeifer, et al.. (2000). New Approaches to Molecular Profiling of Tissue Samples. Analytical Cellular Pathology. 20(1). 1–6. 8 indexed citations

19.

Afonso, Anoushka M., Michael R. Emmert‐Buck, Paul H. Duray, et al.. (1999). LOSS OF HETEROZYGOSITY ON CHROMOSOME 13 IS ASSOCIATED WITH ADVANCED STAGE PROSTATE CANCER. The Journal of Urology. 162(3 Part 1). 922–926. 17 indexed citations

20.

Debelenko, Larisa V., Michael R. Emmert‐Buck, Pachiappan Manickam, et al.. (1997). Haplotype analysis defines a minimal interval for the multiple endocrine neoplasia type 1 (MEN1) gene.. PubMed. 57(6). 1039–42. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact